Literature DB >> 8058337

Overexpression of the Grb2 gene in human breast cancer cell lines.

R J Daly1, M D Binder, R L Sutherland.   

Abstract

A receptor blotting technique was used to detect SH2 domain containing epidermal growth factor receptor (EGFR) substrates that exhibited differential expression either between normal breast epithelial cells and breast cancer cells or between different human breast cancer cell lines. This identified a 25 kD protein, subsequently identified as Grb2, which was markedly overexpressed in three breast cancer cell lines (MCF-7, MDA-MB-361 and -453) relative to both normal breast epithelial cells and the majority of breast cancer cell lines. Northern blot analysis revealed that 7/19 breast cancer cell lines exhibited more than twofold overexpression of Grb2 mRNA, with overexpression correlating with high expression of erbB receptors. In MCF-7, MDA-MB-361 and -453 cells the overexpression of Grb2 mRNA and protein was accompanied by a small amplification of the Grb2 gene locus. Overexpression of Grb2 correlated with increased complex formation between Grb2 and the hSos-1 Ras GDP-GTP exchange protein. This upregulation of the Ras signalling pathway might modulate the growth factor sensitivity of human breast cancer cells and therefore play a role in tumour progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058337

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Bivalent binding drives the formation of the Grb2-Gab1 signaling complex in a noncooperative manner.

Authors:  Caleb B McDonald; Vikas Bhat; David C Mikles; Brian J Deegan; Kenneth L Seldeen; Amjad Farooq
Journal:  FEBS J       Date:  2012-05-09       Impact factor: 5.542

2.  The adaptor proteins p66Shc and Grb2 regulate the activation of the GTPases ARF1 and ARF6 in invasive breast cancer cells.

Authors:  Eric Haines; Caroline Saucier; Audrey Claing
Journal:  J Biol Chem       Date:  2014-01-09       Impact factor: 5.157

3.  Activation of the JNK pathway is essential for transformation by the Met oncogene.

Authors:  G A Rodrigues; M Park; J Schlessinger
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

4.  Conservation of protein abundance patterns reveals the regulatory architecture of the EGFR-MAPK pathway.

Authors:  Tujin Shi; Mario Niepel; Jason E McDermott; Yuqian Gao; Carrie D Nicora; William B Chrisler; Lye M Markillie; Vladislav A Petyuk; Richard D Smith; Karin D Rodland; Peter K Sorger; Wei-Jun Qian; H Steven Wiley
Journal:  Sci Signal       Date:  2016-07-12       Impact factor: 8.192

5.  The null oncogene hypothesis and protection from cancer.

Authors:  M P Davenport; R L Ward; N J Hawkins
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

6.  Grb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel.

Authors:  Brunilde Gril; Michel Vidal; Franck Assayag; Marie-France Poupon; Wang-Qing Liu; Christiane Garbay
Journal:  Int J Cancer       Date:  2007-07-15       Impact factor: 7.396

Review 7.  SH2 domain-containing signaling proteins in human breast cancer.

Authors:  R J Daly
Journal:  Breast Cancer Res Treat       Date:  1995-04       Impact factor: 4.872

Review 8.  Grb2 signaling in cell motility and cancer.

Authors:  Alessio Giubellino; Terrence R Burke; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2008-08       Impact factor: 6.902

9.  p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation.

Authors:  Stephanie J Moeller; Elizabeth D Head; Robert J Sheaff
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

10.  Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta.

Authors:  Amy J Galliher-Beckley; William P Schiemann
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.